UB Paderborn / Katalog / Suche / in CDI

B-cell receptor signaling as a driver of lymphoma development and evolution

Seminars in cancer biology, 2013-12, Vol.23 (6), p.410-421

2013

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

The lancet oncology, 2015-02, Vol.16 (2), p.169-176

2015

Link zum Volltext

Verfügbarkeit prüfen

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies

Seminars in hematology, 2022-10, Vol.59 (4), p.175-176

Wiestner, Adrian

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting B cell receptor signalling in cancer: preclinical and clinical advances

Nature reviews. Cancer, 2018-03, Vol.18 (3), p.148

2018

Link zum Volltext

Verfügbarkeit prüfen

Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy

Leukemia & lymphoma, 2019-01, Vol.60 (2), p.519-522

2019

Link zum Volltext

Verfügbarkeit prüfen

Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1

Leukemia & lymphoma, 2011-09, Vol.52 (9), p.1758-1769

2011

Link zum Volltext

Verfügbarkeit prüfen

Choosing frontline chemoimmunotherapy for CLL

The lancet oncology, 2016-07, Vol.17 (7), p.852-854

Wiestner, Adrian

2016

Link zum Volltext

Verfügbarkeit prüfen

Chronic Lymphocytic Leukemia: Moving Forward—Rapidly

Seminars in hematology, 2014-07, Vol.51 (3), p.157-157

2014

Link zum Volltext

Verfügbarkeit prüfen

Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?

Hematology/oncology clinics of North America, 2021-08, Vol.35 (4), p.827-845

2021

Link zum Volltext

Verfügbarkeit prüfen

PROLONGing remissions in patients with CLL

The lancet oncology, 2015-10, Vol.16 (13), p.1282-1284

Wiestner, Adrian

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia

Leukemia & lymphoma, 2018-12, Vol.59 (12), p.2792-2800

2018

Link zum Volltext

Verfügbarkeit prüfen

Do mantle cell lymphomas have an ‘Achilles heel’?

Current opinion in hematology, 2014-07, Vol.21 (4), p.350-357

2014

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccines for patients with haematological conditions

The Lancet. Haematology, 2021-05, Vol.8 (5), p.e312-e314

2021

Link zum Volltext

Verfügbarkeit prüfen

An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia

Nature genetics, 1998-01, Vol.18 (1), p.49-52

1998

Link zum Volltext

Verfügbarkeit prüfen

Under the microscope: CCL3 and T cells in the microenvironment of chronic lymphocytic leukemia

Leukemia & lymphoma, 2016-03, Vol.57 (3), p.501-502

2016

Link zum Volltext

Verfügbarkeit prüfen

Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL

Leukemia & lymphoma, 2023-12, Vol.64 (14), p.2306-2315

2023

Link zum Volltext

Verfügbarkeit prüfen

Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications

Hematology/oncology clinics of North America, 2013-04, Vol.27 (2), p.173-206

2013

Link zum Volltext

Verfügbarkeit prüfen

New molecular targets in mantle cell lymphoma

Seminars in cancer biology, 2011-11, Vol.21 (5), p.335-346

2011

Link zum Volltext

Verfügbarkeit prüfen

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Leukemia & lymphoma, 2020-08, Vol.61 (10), p.2375-2382

2020

Link zum Volltext

Verfügbarkeit prüfen

Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia

Academic radiology, 2023-06, Vol.30 (6), p.1056-1065

2023

Link zum Volltext

Verfügbarkeit prüfen

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

JAMA oncology, 2016-12, Vol.2 (12), p.1656

2016

Link zum Volltext

Verfügbarkeit prüfen

Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade

Seminars in oncology, 2016-04, Vol.43 (2), p.222-232

2016

Link zum Volltext

Verfügbarkeit prüfen

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia

JAMA dermatology (Chicago, Ill.), 2016-06, Vol.152 (6), p.698

2016

Link zum Volltext

Verfügbarkeit prüfen

Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma

Leukemia & lymphoma, 2021-07, Vol.62 (8), p.1828-1839

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

B-cell receptor signaling as a driver of lymphoma development and evolution

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies

Targeting B cell receptor signalling in cancer: preclinical and clinical advances

Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy

Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1

Choosing frontline chemoimmunotherapy for CLL

Chronic Lymphocytic Leukemia: Moving Forward—Rapidly

Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?

PROLONGing remissions in patients with CLL

Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia

Do mantle cell lymphomas have an ‘Achilles heel’?

COVID-19 vaccines for patients with haematological conditions

An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia

Under the microscope: CCL3 and T cells in the microenvironment of chronic lymphocytic leukemia

Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL

Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications

Molecular map of chronic lymphocytic leukemia and its impact on outcome

New molecular targets in mantle cell lymphoma

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia

Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma

Aktive Filter

Suchergebnisse filtern